Judith Gottwein

Professor

University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Judith Gottwein is a Professor at the University of Copenhagen, Denmark. Her research focuses on virology, specifically the mechanisms of resistance in SARS-CoV-2 and hepatitis C virus. Recent articles include studies on nirmatrelvir-resistant mutants and the development of a vaccine against hepatitis C. She aims to advance understanding of viral replication and resistance mechanisms to inform therapeutic strategies.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (16)

Ulrik Fahnøe

Københavns Universitet

DENMARK

Judith Gottwein

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Replication capacity and susceptibility of nirmatrelvir-resistant mutants to next-generation Mpro inhibitors in a SARS-CoV-2 replicon system

Inactivated genotype 1a, 2a and 3a HCV vaccine candidates induced broadly neutralising antibodies in mice

An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals

Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system

Identification of novel neutralizing determinants for protection against HCV

Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.

Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412–425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles

Toward a vaccine against hepatitis C virus.

Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.

Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

Inactivated whole hepatitis C virus vaccine employing a licensed adjuvant elicits cross-genotype neutralizing antibodies in mice

Collaborators (16)

Ulrik Fahnøe

Jeppe Vinther

Jannick Prentoe

Henrik Elvang Jensen

Julius Elliot Raagaard Grothen

Jan Christensen

Anna Sherwood

Katarzyna Grzyb

Jens Bukh

Santseharay Ramirez Almeida

Henrik Krarup

Helena Damtoft Tjørnelund

Troels Scheel

Kenn Holmbeck

Agnieszka Podolska-Charlery

Günther H.J. Peters

Make your next move.